OTR

U.S. Xpress Honors 153 Professional Drivers for 180 Million Safe Miles

Retrieved on: 
Friday, April 29, 2022
Supply Chain Management, Trucking, Logistics, Supply Chain Management, Retail, Transport, Solution, NYSE, CEO, Variant, USX, COVID-19, Company, Multimedia, Breakfast, Industry, OTR, Xpress technology, Xpress, Video game, Dedicated

U.S. Xpress (NYSE: USX) honored 153 of its professional truck drivers from its U.S. Xpress and Variant brands for more than 180 million combined miles of safe driving during an awards ceremony this week at the companys Chattanooga, Tenn., headquarters.

Key Points: 
  • U.S. Xpress (NYSE: USX) honored 153 of its professional truck drivers from its U.S. Xpress and Variant brands for more than 180 million combined miles of safe driving during an awards ceremony this week at the companys Chattanooga, Tenn., headquarters.
  • Two Variant drivers, Larry Holmes from Dothan, Ala., and Johnny Loftis from Reidsville, N.C., reached more than 3 million miles each throughout their careers.
  • U.S. Xpress driver William Freelove of Rome, Ga. reached 3 million safe miles and was recognized as the longest tenured driver in attendance.
  • U.S. Xpress will hold another awards ceremony in June, recognizing drivers with mileage milestones that occurred in 2021.

Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo

Retrieved on: 
Wednesday, April 27, 2022
Health, Other Science, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Patient, Medicine, OTR, Caffeine, Adoption, Brickell Avenue, Proxy, Freedom, Sale, Suite, Growth, Conference, Person, Solution, Failure, SPAC, Technology, Form, Prospectus, Nasdaq, Communication, Reading, SEC, Registration statement, 100,000, Register, Forward-looking statement, Safety, Industry, Acquisition, Securities Act of 1933, Risk, Viscosity, View, Pharmaceutical industry, Vaccine, Security (finance), Risk management, Holding company, Ownership

Comera Life Sciences, Inc. , which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced that Robert P. Mahoney, Ph.D., Chief Scientific Officer, will present at the PEGS Boston Conference & Expo, being held May 2-6, 2022, in-person.

Key Points: 
  • Comera Life Sciences, Inc. , which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced that Robert P. Mahoney, Ph.D., Chief Scientific Officer, will present at the PEGS Boston Conference & Expo, being held May 2-6, 2022, in-person.
  • Leading a compassionate new era in medicine, Comera Life Sciences is applying a deep knowledge of formulation science and technology to transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms.
  • On January 31, 2022, Comera Life Sciences and OTR Acquisition Corp. (Nasdaq: OTRA) (OTR), a publicly traded special purpose acquisition company (SPAC), announced a proposed business combination.
  • To learn more about the Comera Life Sciences mission, as well as the proprietary SQore platform, visit https://comeralifesciences.com .

New Studies Demonstrate Clinical Benefits of Patient- and Provider-Supportive Technology in Diabetes Management

Retrieved on: 
Wednesday, April 27, 2022
ATTD, Health, T1D, Technology, OTR, Journal of Diabetes Science and Technology, Adoption, Telephone, Obesity, COVID-19, Blood, Bluetooth, Research, Weight loss, Diagnosis, Caregiver, A1C, Treatment, Patient, Conference, Type 2 diabetes, Telehealth, Overweight, T2D, HCPS, Global Medical Device Nomenclature, BGM, Solution, American Association of Clinical Endocrinologists, Method, Journal, Meal, Multimedia, International Conference on Information Systems Security and Privacy, Quality of life, HCP, Prevalence, COVID, OneTouch Ultra, Trust, Honda advanced technology, Medical device, Pharmaceutical industry, Satellite navigation device, Mobile phone, Safety, Acnalbasac Noom, LifeScan, Diabetes

MALVERN, Pa., April 27, 2022 /PRNewswire/ -- LifeScan, a world leader in blood glucose monitoring, announced today the presentation of three studies showing the value of app-based technology in improving diabetes management. The three studies, presented at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), examined the use of different technologies in various patient populations, and all similarly concluded that a clear benefit was observed for healthcare providers and patients with diabetes.

Key Points: 
  • A second study analyzed the benefit of 16 weeks of free access to Noom's app-based weight loss program for people living with type 2 diabetes.
  • "Our goal at LifeScan is to offer people living with and treating diabetes the digital tools and connected solutions that can make its management easier and more successful.
  • Blood glucose monitors (BGM) are vital for over 95% of people with diabetes who monitor their blood glucose.
  • The aim was to understand the impact digital diabetes management solutions, like OTR, had during the pandemic.

Simple Tire Announces Executive Promotion

Retrieved on: 
Monday, April 25, 2022
Online Retail, Retail, Tires & Rubber, General Automotive, Automotive, CEO, OTR, ATV, COO, Inc. (magazine), Growth, Pratt, Commercial, Original equipment manufacturer, Partnership, Industry, Antique, Company, Heavy equipment, Agriculture, Industrial

Simple Tire, a leading Philadelphia-based online tire retailer that is part of the Dealer Tire Family of Companies, today announced that Chief Executive Officer Andy Chalofsky will depart Simple Tire as part of a planned succession, promoting President Karthik Iyer to the expanded role of President and CEO.

Key Points: 
  • Simple Tire, a leading Philadelphia-based online tire retailer that is part of the Dealer Tire Family of Companies, today announced that Chief Executive Officer Andy Chalofsky will depart Simple Tire as part of a planned succession, promoting President Karthik Iyer to the expanded role of President and CEO.
  • In 2012, brothers Andy and current Chief Operating Officer Josh Chalofsky developed the concept for Simple Tire while working in their family's brick and mortar tire business.
  • Based in Philadelphia, Simple Tire is an online tire retailer committed to relentlessly reinventing tire replacement to make it way simple, way better.
  • In 2022 and 2020, Simple Tire was named the Best Place to Work in the tire industry by Tire Business Magazine and was previously on Inc. Magazine's list of fastest growing companies in 2019.

Australia Automotive Coolant Market Report to 2025 - Featuring Royal Dutch Shell, Castrol Australia and Penrite Oil Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, April 22, 2022
Aftermarket, Automotive, Automotive Manufacturing, Oil, Gas, Manufacturing, Energy, OTR, Ethylene glycol, COVID-19, Propylene glycol, Glycerol, CAGR, Ownership, Growth, The, Lubricant, Policy, USD, Industry, COVID, Taxicab, Technology

The "Australia Automotive Coolant Market by Vehicle Type, Product Type, Technology, Demand Category and Region: Forecast & Opportunities to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Australia Automotive Coolant Market by Vehicle Type, Product Type, Technology, Demand Category and Region: Forecast & Opportunities to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The Australian Automotive Coolant Market was valued at USD 267.06 Million in 2019 and is forecast to grow at CAGR of over 9% in the next five years to reach USD 340.61 Million by 2025.
  • Anticipated growth in the market can be attributed to rising demand of passenger cars, coupled with increase in construction and mining activities in the country.
  • The Australian Automotive Coolant Market is segmented based on vehicle type, product type, technology, demand category and region.

U.S. Xpress Goes “OnRoad” With Comdata

Retrieved on: 
Friday, April 22, 2022
Trucking, Finance, Automotive, Transport, Banking, Accounting, Professional Services, Logistics, Supply Chain Management, Fleet Management, Health, OTR, Mastercard, Xpress technology, Fleetcor, USX, Company, Solution, NYSE, FLEETCOR, Industry, Partnership, Financial services, Online shopping, Dedicated, Comdata

U.S. Xpress will implement use of Comdatas OnRoad program to accommodate and facilitate both company and driver purchases.

Key Points: 
  • U.S. Xpress will implement use of Comdatas OnRoad program to accommodate and facilitate both company and driver purchases.
  • The Comdata OnRoad Card is a universally accepted MasterCard with access to both the Comdata Proprietary and MasterCard Signature Debit networks.
  • With OnRoad, professional drivers can receive fund disbursements (payroll, settlements, reimbursements) and company funds all on one card.
  • U.S. Xpress brokerage offering provides greater capacity for shippers, and for carriers, tools and resources through its subsidiary, Xpress Technologies , to better manage and grow their business.

European $57 Billion Tire Markets, Competition, Forecast & Opportunities, 2027 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 20, 2022
Automotive, Tires & Rubber, OTR, Competition, Medium, Car, Weather, Transport, CAGR, Forecast, Growth, Construction, Country, Industry, Rail transport, Road, Atlantic Ocean

The European Tire Market is anticipated to grow with a CAGR of 3.84% during the forecast period, 2023-2027, to achieve a market value of USD57,300.78 million by 2027.

Key Points: 
  • The European Tire Market is anticipated to grow with a CAGR of 3.84% during the forecast period, 2023-2027, to achieve a market value of USD57,300.78 million by 2027.
  • The growing number of passenger cars and light commercial vehicle for regular transportation and commutes further drives the growth of the European Tire Market in the upcoming five years.
  • Moreover, the surging demand for replacement tires for personal vehicles also supports the growth of the European Tire Market through 2027.
  • The European Tire Market is segmented by vehicle type, demand category, tire construction type, rim size, sales channel, country analysis, and competitional landscape.

Comera Life Sciences and Intas Pharmaceuticals Announce Research Collaboration

Retrieved on: 
Tuesday, April 19, 2022
Health, Other Health, Other Science, Research, Science, Pharmaceutical, Biotechnology, Intas Biopharmaceuticals, Medicine, OTR, Adoption, Marketing, Research, Brickell Avenue, Annual report, API, Freedom, Sale, Suite, Patient, Growth, Person, Failure, SPAC, Technology, Form, Prospectus, Nasdaq, Communication, Reading, 100,000, SEC, Forward-looking statement, Register, Safety, USD, Multimedia, Industry, Partnership, Acquisition, Securities Act of 1933, Risk, Pharmaceutical industry, Risk management, Security (finance), Holding company, Ownership

Today, Comera Life Sciences, Inc. (Comera or the Company) and Intas Pharmaceuticals Ltd. (Intas) announced a research collaboration to develop a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience.

Key Points: 
  • Today, Comera Life Sciences, Inc. (Comera or the Company) and Intas Pharmaceuticals Ltd. (Intas) announced a research collaboration to develop a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience.
  • We are excited to work with Comera to enhance therapeutic options and access for patients, said Binish Chudgar, Vice Chairman and Managing Director of Intas Pharmaceuticals.
  • Leading a compassionate new era in medicine, Comera Life Sciences is applying a deep knowledge of formulation science and technology to transform essential biologic medicines.
  • To learn more about the Comera Life Sciences mission, as well as the proprietary SQore platform, visit https://comeralifesciences.com/ .

Comera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination

Retrieved on: 
Monday, April 18, 2022
General Health, Professional Services, Health, Finance, Medicine, OTR, Adoption, Nasdaq, U.S. Securities and Exchange Commission, Security (finance), Brickell Avenue, Proxy, Freedom, Sale, Suite, Patient, Special, Growth, Person, Failure, SPAC, Technology, Form, Prospectus, Communication, Reading, Registration statement, SEC, 100,000, Register, Forward-looking statement, Safety, Multimedia, Industry, Acquisition, Securities Act of 1933, Risk, Online gambling, Risk management, Holding company, Ownership

On January 31, 2022, Comera and OTR announced the proposed business combination.

Key Points: 
  • On January 31, 2022, Comera and OTR announced the proposed business combination.
  • To learn more about the Comera Life Sciences mission, as well as the proprietary SQore platform, visit https://comeralifesciences.com/ .
  • In connection with the proposed business combination, Comera Life Sciences Holdings, Inc. (Holdco) filed the Registration Statement which includes a proxy statement of OTR and a prospectus of Holdco.
  • Neither Holdco, Comera nor OTR gives any assurance that either Comera or OTR will achieve its expectations.

E-commerce Driving the United States 3PL Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - ResearchAndMarkets.com

Retrieved on: 
Friday, April 15, 2022
Retail, Online Retail, COVID-19, J. B. Hunt, Health, OTR, Shopify, CAGR, CH, 3PL, Efficiency, List of E. Schweizerbart serials, Technology, XPO Logistics, CMA, Amazon, Attention, Beauty salon, Warehouse, Online shopping, Expeditors International, Growth

The "United States 3PL Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States 3PL Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.
  • The United States 3PL market is expected to grow at a CAGR of over 6% during the forecast period of 2022-2027.
  • The 3PL market in the United States is driven by the increasing level of cross-border trade.
  • In addition, the cost benefits of using 3PL are anticipated to boost the growth of the 3PL market.